Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China
Clinical trial NCT03908307 · COMPLETED
Trial details
- NCT number
- NCT03908307
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2021-09-26
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.